GTx, Inc. to Participate in the Baird 2018 Global Healthcare Conference
Aug. 30, 2018
MEMPHIS, Tenn.--(BUSINESS WIRE)--Aug 30, 2018--GTx, Inc. (Nasdaq: GTXI) today announced that Robert J. Wills, PhD, Executive Chairman, and other senior executive management team members will present a company overview at the Baird 2018 Global Healthcare Conference on Thursday, September 6, 2018 at 9:05 am ET in New York.
A simultaneous webcast of the presentation can be accessed by visiting the investor relations section of the GTx website at http://www.gtxinc.com. A replay of the presentation will also be available and archived on the site for 30 days.
GTx, Inc., headquartered in Memphis, Tenn., is a biopharmaceutical company dedicated to the discovery, development and commercialization of medicines to treat serious and/or significant unmet medical conditions, including stress urinary incontinence and prostate cancer.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005108/en/
CONTACT: GTx, Inc.
Kimberly Minarovich or Sam Martin
Red House Consulting
Denise Powell, 510-703-9491
KEYWORD: UNITED STATES NORTH AMERICA TENNESSEE
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL
SOURCE: GTx, Inc.
Copyright Business Wire 2018.
PUB: 08/30/2018 07:00 AM/DISC: 08/30/2018 07:01 AM